Copyright: ©Author(s) 2026.
World J Diabetes. Jun 15, 2026; 17(6): 117524
Published online Jun 15, 2026. doi: 10.4239/wjd.117524
Published online Jun 15, 2026. doi: 10.4239/wjd.117524
Figure 6 Shenqi Jiangtang Granules enhance antioxidant defense of H9C2 cells under glucolipotoxicity.
A: Intracellular free iron quantified by colorimetric assay; B: Malondialdehyde (MDA), the end product of lipid peroxidation, measured using the thiobarbituric acid-MDA condensation assay; C: Superoxide dismutase activity quantified by the WST-1 method; D: Glutathione peroxidase activity quantified by colorimetric assay; E: Glutathione quantified by the 5,5′-dithiobis-(2-nitrobenzoic acid) colorimetric/spectrophotometric assay; F and G: Flow cytometric detection of reactive oxygen species-positive cells using fluorescent probes (n = 3). aP < 0.05 vs control; bP < 0.01 vs control; cP < 0.05 vs model group; dP < 0.01 vs model group; eP < 0.05 vs Shenqi Jiangtang Granules-high (SQJT-H) + brequinar (BRQ); fP < 0.01 vs SQJT-H + BRQ. Con: Control; Mod: Model; SQJT: Shenqi Jiangtang Granules; MDA: Malondialdehyde; SOD: Superoxide dismutase; GSH: Glutathione; GSH-Px: Glutathione peroxidase; ROS: Reactive oxygen species.
- Citation: Tang YT, Chen YP, Yang YN, Liu JL, Wu Q, Zhang S, Pang Q, Wei MY, Gong YB, Ni Q. Shenqi Jiangtang Granules attenuate ferroptosis in diabetic cardiomyopathy via the dihydroorotate dehydrogenase-coenzyme Q pathway. World J Diabetes 2026; 17(6): 117524
- URL: https://www.wjgnet.com/1948-9358/full/v17/i6/117524.htm
- DOI: https://dx.doi.org/10.4239/wjd.117524